Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.
Identifieur interne : 003187 ( Ncbi/Curation ); précédent : 003186; suivant : 003188Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.
Auteurs : Julia M L. Brotherton [Australie] ; Mark Jit [Royaume-Uni] ; Patti E. Gravitt [États-Unis] ; Marc Brisson [Canada] ; Aimée R. Kreimer [États-Unis] ; Sara I. Pai [États-Unis] ; Carole Fakhry [États-Unis] ; Joseph Monsonego [France] ; Silvia Franceschi [France]Source :
- International journal of cancer [ 1097-0215 ] ; 2016.
Descripteurs français
- KwdFr :
- Dépistage systématique, Europe (épidémiologie), Femelle, Humains, Incidence, Infections à papillomavirus (), Mâle, Tumeurs (), Tumeurs (épidémiologie), Tumeurs (étiologie), Tumeurs de la tête et du cou (), Tumeurs de la tête et du cou (épidémiologie), Tumeurs de la tête et du cou (étiologie), Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (anatomopathologie), Tumeurs du col de l'utérus (épidémiologie), Tumeurs du col de l'utérus (étiologie), Vaccination, Vaccins contre les papillomavirus (), Vaccins contre les papillomavirus (administration et posologie), Vaccins contre les papillomavirus (effets indésirables), Vaccins contre les papillomavirus (immunologie), Évaluation de résultat (soins).
- MESH :
- administration et posologie : Vaccins contre les papillomavirus.
- anatomopathologie : Tumeurs du col de l'utérus.
- effets indésirables : Vaccins contre les papillomavirus.
- immunologie : Vaccins contre les papillomavirus.
- épidémiologie : Europe, Tumeurs, Tumeurs de la tête et du cou, Tumeurs du col de l'utérus.
- étiologie : Tumeurs, Tumeurs de la tête et du cou, Tumeurs du col de l'utérus.
- Dépistage systématique, Femelle, Humains, Incidence, Infections à papillomavirus, Mâle, Tumeurs, Tumeurs de la tête et du cou, Tumeurs du col de l'utérus, Vaccination, Vaccins contre les papillomavirus, Évaluation de résultat (soins).
English descriptors
- KwdEn :
- Europe (epidemiology), Female, Head and Neck Neoplasms (epidemiology), Head and Neck Neoplasms (etiology), Head and Neck Neoplasms (prevention & control), Humans, Incidence, Male, Mass Screening, Neoplasms (epidemiology), Neoplasms (etiology), Neoplasms (prevention & control), Outcome Assessment (Health Care), Papillomavirus Infections (prevention & control), Papillomavirus Vaccines (administration & dosage), Papillomavirus Vaccines (adverse effects), Papillomavirus Vaccines (classification), Papillomavirus Vaccines (immunology), Uterine Cervical Neoplasms (epidemiology), Uterine Cervical Neoplasms (etiology), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (prevention & control), Vaccination.
- MESH :
- chemical , administration & dosage : Papillomavirus Vaccines.
- chemical , adverse effects : Papillomavirus Vaccines.
- chemical , classification : Papillomavirus Vaccines.
- epidemiology : Europe, Head and Neck Neoplasms, Neoplasms, Uterine Cervical Neoplasms.
- etiology : Head and Neck Neoplasms, Neoplasms, Uterine Cervical Neoplasms.
- chemical , immunology : Papillomavirus Vaccines.
- pathology : Uterine Cervical Neoplasms.
- prevention & control : Head and Neck Neoplasms, Neoplasms, Papillomavirus Infections, Uterine Cervical Neoplasms.
- Female, Humans, Incidence, Male, Mass Screening, Outcome Assessment (Health Care), Vaccination.
Abstract
This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.
DOI: 10.1002/ijc.30063
PubMed: 26916230
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001B54
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001B30
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001B30
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003187
Links to Exploration step
pubmed:26916230Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.</title><author><name sortKey="Brotherton, Julia M L" sort="Brotherton, Julia M L" uniqKey="Brotherton J" first="Julia M L" last="Brotherton">Julia M L. Brotherton</name><affiliation wicri:level="1"><nlm:affiliation>National HPV Vaccination Program Register, VCS Registries, East Melbourne, Vic, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>National HPV Vaccination Program Register, VCS Registries, East Melbourne, Vic</wicri:regionArea><wicri:noRegion>Vic</wicri:noRegion></affiliation></author><author><name sortKey="Jit, Mark" sort="Jit, Mark" uniqKey="Jit M" first="Mark" last="Jit">Mark Jit</name><affiliation wicri:level="3"><nlm:affiliation>Modelling and Economics Unit, Public Health England, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Modelling and Economics Unit, Public Health England, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Gravitt, Patti E" sort="Gravitt, Patti E" uniqKey="Gravitt P" first="Patti E" last="Gravitt">Patti E. Gravitt</name><affiliation wicri:level="2"><nlm:affiliation>Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Nouveau-Mexique</region></placeName><wicri:cityArea>Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque</wicri:cityArea></affiliation></author><author><name sortKey="Brisson, Marc" sort="Brisson, Marc" uniqKey="Brisson M" first="Marc" last="Brisson">Marc Brisson</name><affiliation wicri:level="1"><nlm:affiliation>Département de Médecine Sociale et Préventive, Université Laval, Québec, QC, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Département de Médecine Sociale et Préventive, Université Laval, Québec, QC</wicri:regionArea><wicri:noRegion>QC</wicri:noRegion></affiliation></author><author><name sortKey="Kreimer, Aimee R" sort="Kreimer, Aimee R" uniqKey="Kreimer A" first="Aimée R" last="Kreimer">Aimée R. Kreimer</name><affiliation wicri:level="2"><nlm:affiliation>Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Pai, Sara I" sort="Pai, Sara I" uniqKey="Pai S" first="Sara I" last="Pai">Sara I. Pai</name><affiliation wicri:level="2"><nlm:affiliation>Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Fakhry, Carole" sort="Fakhry, Carole" uniqKey="Fakhry C" first="Carole" last="Fakhry">Carole Fakhry</name><affiliation wicri:level="2"><nlm:affiliation>Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Outpatient Center, Baltimore, MD.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Outpatient Center, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Monsonego, Joseph" sort="Monsonego, Joseph" uniqKey="Monsonego J" first="Joseph" last="Monsonego">Joseph Monsonego</name><affiliation wicri:level="1"><nlm:affiliation>Institut du Col, 174 Rue de Courcelles, Paris, 75017, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut du Col, 174 Rue de Courcelles, Paris, 75017</wicri:regionArea><wicri:noRegion>75017</wicri:noRegion><wicri:noRegion>75017</wicri:noRegion></affiliation></author><author><name sortKey="Franceschi, Silvia" sort="Franceschi, Silvia" uniqKey="Franceschi S" first="Silvia" last="Franceschi">Silvia Franceschi</name><affiliation wicri:level="1"><nlm:affiliation>International Agency for Research on Cancer, 69372 Lyon cedex 08, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, 69372 Lyon cedex 08</wicri:regionArea><wicri:noRegion>69372 Lyon cedex 08</wicri:noRegion><wicri:noRegion>69372 Lyon cedex 08</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26916230</idno><idno type="pmid">26916230</idno><idno type="doi">10.1002/ijc.30063</idno><idno type="wicri:Area/PubMed/Corpus">001B54</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B54</idno><idno type="wicri:Area/PubMed/Curation">001B30</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B30</idno><idno type="wicri:Area/PubMed/Checkpoint">001B30</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B30</idno><idno type="wicri:Area/Ncbi/Merge">003187</idno><idno type="wicri:Area/Ncbi/Curation">003187</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.</title><author><name sortKey="Brotherton, Julia M L" sort="Brotherton, Julia M L" uniqKey="Brotherton J" first="Julia M L" last="Brotherton">Julia M L. Brotherton</name><affiliation wicri:level="1"><nlm:affiliation>National HPV Vaccination Program Register, VCS Registries, East Melbourne, Vic, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>National HPV Vaccination Program Register, VCS Registries, East Melbourne, Vic</wicri:regionArea><wicri:noRegion>Vic</wicri:noRegion></affiliation></author><author><name sortKey="Jit, Mark" sort="Jit, Mark" uniqKey="Jit M" first="Mark" last="Jit">Mark Jit</name><affiliation wicri:level="3"><nlm:affiliation>Modelling and Economics Unit, Public Health England, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Modelling and Economics Unit, Public Health England, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Gravitt, Patti E" sort="Gravitt, Patti E" uniqKey="Gravitt P" first="Patti E" last="Gravitt">Patti E. Gravitt</name><affiliation wicri:level="2"><nlm:affiliation>Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Nouveau-Mexique</region></placeName><wicri:cityArea>Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque</wicri:cityArea></affiliation></author><author><name sortKey="Brisson, Marc" sort="Brisson, Marc" uniqKey="Brisson M" first="Marc" last="Brisson">Marc Brisson</name><affiliation wicri:level="1"><nlm:affiliation>Département de Médecine Sociale et Préventive, Université Laval, Québec, QC, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Département de Médecine Sociale et Préventive, Université Laval, Québec, QC</wicri:regionArea><wicri:noRegion>QC</wicri:noRegion></affiliation></author><author><name sortKey="Kreimer, Aimee R" sort="Kreimer, Aimee R" uniqKey="Kreimer A" first="Aimée R" last="Kreimer">Aimée R. Kreimer</name><affiliation wicri:level="2"><nlm:affiliation>Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Pai, Sara I" sort="Pai, Sara I" uniqKey="Pai S" first="Sara I" last="Pai">Sara I. Pai</name><affiliation wicri:level="2"><nlm:affiliation>Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Fakhry, Carole" sort="Fakhry, Carole" uniqKey="Fakhry C" first="Carole" last="Fakhry">Carole Fakhry</name><affiliation wicri:level="2"><nlm:affiliation>Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Outpatient Center, Baltimore, MD.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Outpatient Center, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Monsonego, Joseph" sort="Monsonego, Joseph" uniqKey="Monsonego J" first="Joseph" last="Monsonego">Joseph Monsonego</name><affiliation wicri:level="1"><nlm:affiliation>Institut du Col, 174 Rue de Courcelles, Paris, 75017, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut du Col, 174 Rue de Courcelles, Paris, 75017</wicri:regionArea><wicri:noRegion>75017</wicri:noRegion><wicri:noRegion>75017</wicri:noRegion></affiliation></author><author><name sortKey="Franceschi, Silvia" sort="Franceschi, Silvia" uniqKey="Franceschi S" first="Silvia" last="Franceschi">Silvia Franceschi</name><affiliation wicri:level="1"><nlm:affiliation>International Agency for Research on Cancer, 69372 Lyon cedex 08, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, 69372 Lyon cedex 08</wicri:regionArea><wicri:noRegion>69372 Lyon cedex 08</wicri:noRegion><wicri:noRegion>69372 Lyon cedex 08</wicri:noRegion></affiliation></author></analytic><series><title level="j">International journal of cancer</title><idno type="eISSN">1097-0215</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Europe (epidemiology)</term><term>Female</term><term>Head and Neck Neoplasms (epidemiology)</term><term>Head and Neck Neoplasms (etiology)</term><term>Head and Neck Neoplasms (prevention & control)</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Mass Screening</term><term>Neoplasms (epidemiology)</term><term>Neoplasms (etiology)</term><term>Neoplasms (prevention & control)</term><term>Outcome Assessment (Health Care)</term><term>Papillomavirus Infections (prevention & control)</term><term>Papillomavirus Vaccines (administration & dosage)</term><term>Papillomavirus Vaccines (adverse effects)</term><term>Papillomavirus Vaccines (classification)</term><term>Papillomavirus Vaccines (immunology)</term><term>Uterine Cervical Neoplasms (epidemiology)</term><term>Uterine Cervical Neoplasms (etiology)</term><term>Uterine Cervical Neoplasms (pathology)</term><term>Uterine Cervical Neoplasms (prevention & control)</term><term>Vaccination</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Dépistage systématique</term><term>Europe (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Infections à papillomavirus ()</term><term>Mâle</term><term>Tumeurs ()</term><term>Tumeurs (épidémiologie)</term><term>Tumeurs (étiologie)</term><term>Tumeurs de la tête et du cou ()</term><term>Tumeurs de la tête et du cou (épidémiologie)</term><term>Tumeurs de la tête et du cou (étiologie)</term><term>Tumeurs du col de l'utérus ()</term><term>Tumeurs du col de l'utérus (anatomopathologie)</term><term>Tumeurs du col de l'utérus (épidémiologie)</term><term>Tumeurs du col de l'utérus (étiologie)</term><term>Vaccination</term><term>Vaccins contre les papillomavirus ()</term><term>Vaccins contre les papillomavirus (administration et posologie)</term><term>Vaccins contre les papillomavirus (effets indésirables)</term><term>Vaccins contre les papillomavirus (immunologie)</term><term>Évaluation de résultat (soins)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Papillomavirus Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Papillomavirus Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="classification" xml:lang="en"><term>Papillomavirus Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins contre les papillomavirus</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins contre les papillomavirus</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Europe</term><term>Head and Neck Neoplasms</term><term>Neoplasms</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Head and Neck Neoplasms</term><term>Neoplasms</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins contre les papillomavirus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Papillomavirus Vaccines</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Head and Neck Neoplasms</term><term>Neoplasms</term><term>Papillomavirus Infections</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Europe</term><term>Tumeurs</term><term>Tumeurs de la tête et du cou</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Tumeurs</term><term>Tumeurs de la tête et du cou</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Mass Screening</term><term>Outcome Assessment (Health Care)</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dépistage systématique</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Infections à papillomavirus</term><term>Mâle</term><term>Tumeurs</term><term>Tumeurs de la tête et du cou</term><term>Tumeurs du col de l'utérus</term><term>Vaccination</term><term>Vaccins contre les papillomavirus</term><term>Évaluation de résultat (soins)</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003187 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003187 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:26916230
|texte= Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:26916230" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |